Lycium barbarum fruits, also known as goji berries, are well known for their beneficial and healthy effects.
Gojired® extract contains many nutrients with high biological activity such as polysaccharides but it’s also rich in carotenoids:
zeaxanthin is the most represented carotenoid in the fruit (31–56% of the total carotenoid content).
Zeaxanthin preferentially accumulates in the human brain and exerts a neuroprotective activity reducing oxidative stress and regulating inflammatory damage.
Gojired® extract is obtained from Italian Goji berries cultivated in Calabria (Sibari Plain), in the Southern of Italy.
Due to its biological properties and the high level of carotenoids, Gojired® can be used as an innovative ingredient to prevent:
cognitive disorders mental impairments neurodegenerative diseases oxidative damages
The antioxidant properties have been evaluated and tested in collaboration with University of Calabria using the following assays:
ORAC DPPH ABTS
Gojired® extract obtained from Calabrian Goji has higher levels of carotenoids expressed as zeaxanthin compared to other goji extracts, probably due to the sun exposure and the Mediterranean climatic conditions of Sibari Plain.
Moreover, for its carotenoid content, Gojired® can be used in cosmetic application for skin photoprotection, reducing UV-induced free radicals.
1. Pharmacopoeia Hungarica, 7th ed. Budapest, Hungarian Pharmacopeia Commission, Medicina Kanyvkiado, 1986. 3. Bedevian AK. Illustrated polyglottic dictionary of plant names in Latin, Arabic, Armenian, English, French, German, Italian and Turkish languages. Cairo, Argus & Papazian Press, 1936. 4. Hänsel R et al., eds. Hagers Handbuch der pharmazeutischen Praxis. BD. 6: Drogen P-Z, 5th ed. Berlin, Springer-Verlag, 1994.
2. British herbal pharmacopoeia. London British Herbal Medicine Association, 1996.
3. Farnsworth NR, ed. NAPRALERT database. Chicago, University of Illinois at Chicago, IL, February 9, 1998 production (an online database available directly through the University of Illinois at Chicago or through the Scientific and Technical Network (STN) of Chemical Abstracts Services).
4. Bisset NG. Herbal drugs and phytopharmaceuticals. Boca Raton, FL, CRC, CRC Press, 1994.
5. Youngken HW. Textbook of Pharmacognosy, 6th ed. Philadelphia, PA, Blakiston, 1950.
6. Backer CA, Backhuisen van der Brink RC, eds. Flora of Java. Vol. 2. Noordhof, NVP, 1965.
7. Quality control methods for medicinal plant materials. Geneva, World Health Organization, 1998.
8. European pharmacopoeia, 3rd ed. Strasbourg, Council of Europe, 1996.
9. Guidelines for predicting dietary intake of pesticide residues, 2nd rev. ed. Geneva, World Health Organization (document WHO/FSF/FOS/97.7). OMS: monografie di piante medicinali 186
10. ESCOP monographs on the medicinal use of plant drugs. Fascicule 1. Elburg, European Scientific Cooperative on Phytotherapy, 1996. 15. Blumenthal M et al., eds. The complete German Commission E monographs. Austin, TX, American Botanical Council, 1998.
11. Wöbling RH, Milbradt R. Klinik und Therapie des Herpes simplex. Der Allgemainarzt. Vorstellung eines neuen phytotherapeutischen Wirkstoffes. Therapiewoche, 1984, 34:1193-1200.
12. Vogt HJ et al. Melissenextrakt bei Herpes simplex. Allgemeinarzt, 1991, 13:832-841.
13. Wölbling RH, Leonhardt K. Local therapy of herpes simplex with dried extract from Melissa officinalis. Phytomedicine, 1994, 1:25-31
14. JOON-SIK KIM ET AL.: ‘Screening of Anti-angiogenic Activity from Plant Extracts’ KOR. J. PHARMACOGN. vol. 37, no. 4, 2006, pages 253 – 257